Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study - Université Paris-Est-Créteil-Val-de-Marne Access content directly
Journal Articles European Journal of Cancer Year : 2020

Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study

Manon de Vries-Brilland
  • Function : Author
Elouen Boughalem
  • Function : Author
No file

Dates and versions

hal-04242472 , version 1 (15-10-2023)

Identifiers

Cite

Manon de Vries-Brilland, Marine Gross-Goupil, Valérie Seegers, Elouen Boughalem, Benoit Beuselinck, et al.. Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study. European Journal of Cancer, 2020, 136, pp.76-83. ⟨10.1016/j.ejca.2020.02.019⟩. ⟨hal-04242472⟩
22 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More